Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Nov;33(11):1860–1863. doi: 10.1128/aac.33.11.1860

Antileishmanial activities of 2,4-diaminoquinazoline putative dihydrofolate reductase inhibitors.

J D Berman 1, M King 1, N Edwards 1
PMCID: PMC172777  PMID: 2610496

Abstract

2,4-Diaminoquinazoline analogs of folate were assessed as antileishmanial agents and as dihydrofolate reductase inhibitors. Against Leishmania major in human macrophages in vitro, two compounds with tertiary amines attached directly to the quinazoline ring were remarkably active. The 50% effective doses were in the picogram per milliliter range (12 to 91 pg/ml), and the in vitro therapeutic indices were approximately 10(5). These compounds were 1,000 times more active on an absolute basis and had a 100 times more favorable therapeutic index than any compound previously tested in this model. Antileishmanial activity was not correlated with activity against Leishmania mexicana promastigote reductase, which suggests that folate utilization in general, rather than reductase activity specifically, was being inhibited.

Full text

PDF
1860

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avila J. L., Nosei C. Presence of methylenetetrahydrofolate reductase of American Leishmania species and its absence from Trypanosoma species. Mol Biochem Parasitol. 1983 Jan;7(1):1–8. doi: 10.1016/0166-6851(83)90111-1. [DOI] [PubMed] [Google Scholar]
  2. Berman J. D., Lee L. S., Robins R. K., Revankar G. R. Activity of purine analogs against Leishmania tropica within human macrophages in vitro. Antimicrob Agents Chemother. 1983 Aug;24(2):233–236. doi: 10.1128/aac.24.2.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berman J. D., Wyler D. J. An in vitro model for investigation of chemotherapeutic agents in leishmaniasis. J Infect Dis. 1980 Jul;142(1):83–86. doi: 10.1093/infdis/142.1.83. [DOI] [PubMed] [Google Scholar]
  4. Booth R. G., Selassie C. D., Hansch C., Santi D. V. Quantitative structure-activity relationship of triazine-antifolate inhibition of Leishmania dihydrofolate reductase and cell growth. J Med Chem. 1987 Jul;30(7):1218–1224. doi: 10.1021/jm00390a017. [DOI] [PubMed] [Google Scholar]
  5. Davoll J., Johnson A. M., Davies H. J., Bird O. D., Clarke J., Elslager E. F. Folate antagonists. 2. 2,4-Diamino-6-((aralkyl and (heterocyclic)methyl)amino)quinazolines, a novel class of antimetabolites of interest in drug-resistant malaria and Chagas' disease. J Med Chem. 1972 Aug;15(8):812–826. doi: 10.1021/jm00278a007. [DOI] [PubMed] [Google Scholar]
  6. Elslager E. F., Bird O. D., Clarke J., Perricone S. C., Worth D. F. Folate antagonists. 9. 2,4-Diamino-6-((aralkyl)alkylamino)quinazolines, a potent class of antimetabolites with prodigious antimalarial effects. J Med Chem. 1972 Nov;15(11):1138–1146. doi: 10.1021/jm00281a012. [DOI] [PubMed] [Google Scholar]
  7. Elslager E. F., Clarke J., Werbel L. M., Worth D. F., Davoll J. Folate antagonists. 3. 2,4-Diamino-6-(heterocyclic)quinazolines, a novel class of antimetabolites with potent antimalarial and antibacterial activity. J Med Chem. 1972 Aug;15(8):827–836. doi: 10.1021/jm00278a008. [DOI] [PubMed] [Google Scholar]
  8. Elslager E. F., Colbry N. L., Davoll J., Hutt M. P., Johnson J. L., Werbel L. M. Folate antagonists. 22. Antimalarial and antibacterial effects of 2,4-diamino-6-quinazolinesulfonamides. J Med Chem. 1984 Dec;27(12):1740–1743. doi: 10.1021/jm00378a038. [DOI] [PubMed] [Google Scholar]
  9. Grumont R., Sirawaraporn W., Santi D. V. Heterologous expression of the bifunctional thymidylate synthase-dihydrofolate reductase from Leishmania major. Biochemistry. 1988 May 17;27(10):3776–3784. doi: 10.1021/bi00410a039. [DOI] [PubMed] [Google Scholar]
  10. Grumont R., Washtien W. L., Caput D., Santi D. V. Bifunctional thymidylate synthase-dihydrofolate reductase from Leishmania tropica: sequence homology with the corresponding monofunctional proteins. Proc Natl Acad Sci U S A. 1986 Aug;83(15):5387–5391. doi: 10.1073/pnas.83.15.5387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Meek T. D., Garvey E. P., Santi D. V. Purification and characterization of the bifunctional thymidylate synthetase-dihydrofolate reductase from methotrexate-resistant Leishmania tropica. Biochemistry. 1985 Jan 29;24(3):678–686. doi: 10.1021/bi00324a021. [DOI] [PubMed] [Google Scholar]
  12. Neal R. A., Croft S. L. An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani. J Antimicrob Chemother. 1984 Nov;14(5):463–475. doi: 10.1093/jac/14.5.463. [DOI] [PubMed] [Google Scholar]
  13. Santi D. V., Nolan P., Shane B. Folylpolyglutamates in Leishmania major. Biochem Biophys Res Commun. 1987 Aug 14;146(3):1089–1092. doi: 10.1016/0006-291x(87)90759-5. [DOI] [PubMed] [Google Scholar]
  14. Scott D. A., Coombs G. H., Sanderson B. E. Effects of methotrexate and other antifolates on the growth and dihydrofolate reductase activity of Leishmania promastigotes. Biochem Pharmacol. 1987 Jun 15;36(12):2043–2045. doi: 10.1016/0006-2952(87)90508-9. [DOI] [PubMed] [Google Scholar]
  15. Scott D. A., Coombs G. H., Sanderson B. E. Folate utilisation by Leishmania species and the identification of intracellular derivatives and folate-metabolising enzymes. Mol Biochem Parasitol. 1987 Mar;23(2):139–149. doi: 10.1016/0166-6851(87)90149-6. [DOI] [PubMed] [Google Scholar]
  16. Sirawaraporn W., Sertsrivanich R., Booth R. G., Hansch C., Neal R. A., Santi D. V. Selective inhibition of Leishmania dihydrofolate reductase and Leishmania growth by 5-benzyl-2,4-diaminopyrimidines. Mol Biochem Parasitol. 1988 Oct;31(1):79–85. doi: 10.1016/0166-6851(88)90147-8. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES